LA
DXCM icon

Legacy Advisors’s DexCom DXCM Stock Holding History

Legacy Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,929
Closed -$746K – 133
2025
Q1 		$746K Buy
10,929
+895
+9% +$73K 0.08% 203
2024
Q4 		$780K Buy
10,034
+1,315
+15% +$97.4K 0.08% 198
2024
Q3 		$585K Sell
8,719
-817
-9% -$67.1K 0.06% 225
2024
Q2 		$1.08M Buy
9,536
+201
+2% +$25.4K 0.13% 123
2024
Q1 		$1.29M Buy
9,335
+743
+9% +$93.4K 0.16% 110
2023
Q4 		$1.07M Buy
8,592
+2,008
+30% +$205K 0.14% 125
2023
Q3 		$614K Buy
6,584
+852
+15% +$96K 0.1% 167
2023
Q2 		$737K Buy
5,732
+332
+6% +$40.2K 0.11% 141
2023
Q1 		$627K Buy
5,400
+879
+19% +$98.4K 0.12% 130
2022
Q4 		$512K Buy
4,521
+1,418
+46% +$156K 0.09% 143
2022
Q3 		$250K Buy
+3,103
New +$263K 0.06% 187

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Legacy Advisors's DXCM Position: Q2 2025 in Review

Legacy Advisors sold out of DexCom (DXCM) in Q2 2025, closing a stake of 10,929 shares — an estimated $746K sold.

Legacy Advisors first reported a position in DXCM in Q3 2022 and held it in 11 quarters. The position peaked at $1.29M in Q1 2024. 939 funds tracked by Wall St. Rank hold DXCM as of Q2 2025.

  • Legacy Advisors reported no remaining DexCom position as of Q2 2025 after selling out during the quarter.
  • Legacy Advisors sold 10,929 DexCom shares in Q2 2025, an estimated $746K.
  • Legacy Advisors first reported a position in DexCom in Q3 2022 and held it in 11 quarters.
  • Legacy Advisors's DexCom position peaked at $1.29M in Q1 2024.
  • 939 funds tracked by Wall St. Rank held DexCom as of Q2 2025.

Based on Legacy Advisors's 13F filing for Q2 2025, filed 7 Aug 2025.